{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-000036","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2022-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.493398+00:00","generated_at":"2026-06-27T20:56:45.021472+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Biodesix raises ~$16.3M via ATM equity sale, repays $20M of term loan with SVB","bullets":["Raised ~$16.3M from sale of 3,756,994 common shares in ATM offering on Dec 30, 2021.","Entered Consent and Second Amendment to $30M 2021 Term Loan with Silicon Valley Bank on Dec 31, 2021.","Repaid $20M in outstanding principal on Dec 31; $600,000 prepayment fee waived.","Amendment consents to $4.6M milestone payment under Integrated Diagnostics APA in Jan 2022.","Company cites improved financial flexibility to advance strategic growth objectives."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-000036","json":"https://secwatch.observer/filing/0000950170-22-000036.json","markdown":"https://secwatch.observer/filing/0000950170-22-000036.md","text":"https://secwatch.observer/filing/0000950170-22-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022000036/0000950170-22-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022000036/bdsx-20211230.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:56:45.021472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}